132 related articles for article (PubMed ID: 37385531)
1. Advances in the applications of mesenchymal stem cell-conditioned medium in ocular diseases.
Zhang C; Xiao J; Fa L; Jiang F; Jiang H; Zhou L; Xu Z
Exp Eye Res; 2023 Aug; 233():109560. PubMed ID: 37385531
[TBL] [Abstract][Full Text] [Related]
2. Potential of mesenchymal stem cell-derived conditioned medium/secretome as a therapeutic option for ocular diseases.
Bouche Djatche WH; Zhu H; Ma W; Li Y; Li Z; Zhao H; Liu Z; Qiao H
Regen Med; 2023 Oct; 18(10):795-807. PubMed ID: 37702008
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Mesenchymal Stem Cell-Secreted Factors on Delay in Corneal Wound Healing by Nitrogen Mustard.
An S; Shen X; Anwar K; Ashraf M; Lee H; Koganti R; Ghassemi M; Djalilian AR
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232805
[TBL] [Abstract][Full Text] [Related]
4. The Benefits and Hazards of Intravitreal Mesenchymal Stem Cell (MSC) Based-Therapies in the Experimental Ischemic Optic Neuropathy.
Wen YT; Ho YC; Lee YC; Ding DC; Liu PK; Tsai RK
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672743
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.
Navas A; Magaña-Guerrero FS; Domínguez-López A; Chávez-García C; Partido G; Graue-Hernández EO; Sánchez-García FJ; Garfias Y
Stem Cells Transl Med; 2018 Dec; 7(12):906-917. PubMed ID: 30260581
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival Administration of Mesenchymal Stem Cells Alleviates Ocular Inflammation in a Murine Model of Corneal Alkali Burn.
Chen M; Chen X; Li X; Wang J; Wu J; Wang Q; Huang Y; Li Z; Wang L
Stem Cells; 2023 Jun; 41(6):592-602. PubMed ID: 37061809
[TBL] [Abstract][Full Text] [Related]
7. Conditioned Medium from Bone Marrow Mesenchymal Stem Cells Restored Oxidative Stress-Related Impaired Osteogenic Differentiation.
Saleem R; Mohamed-Ahmed S; Elnour R; Berggreen E; Mustafa K; Al-Sharabi N
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948255
[TBL] [Abstract][Full Text] [Related]
8. Effect of Rho-Associated Kinase Inhibitor and Mesenchymal Stem Cell-Derived Conditioned Medium on Corneal Endothelial Cell Senescence and Proliferation.
Jung B; Lee H; Kim S; Tchah H; Hwang C
Cells; 2021 Jun; 10(6):. PubMed ID: 34207965
[TBL] [Abstract][Full Text] [Related]
9. Human Mesenchymal Stem Cell Secretome from Bone Marrow or Adipose-Derived Tissue Sources for Treatment of Hypoxia-Induced Pulmonary Epithelial Injury.
Shologu N; Scully M; Laffey JG; O'Toole D
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274394
[TBL] [Abstract][Full Text] [Related]
10. TSG-6 in conditioned media from adipose mesenchymal stem cells protects against visual deficits in mild traumatic brain injury model through neurovascular modulation.
Jha KA; Pentecost M; Lenin R; Gentry J; Klaic L; Del Mar N; Reiner A; Yang CH; Pfeffer LM; Sohl N; Gangaraju R
Stem Cell Res Ther; 2019 Nov; 10(1):318. PubMed ID: 31690344
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
[TBL] [Abstract][Full Text] [Related]
12. Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium.
Nakahara M; Okumura N; Kay EP; Hagiya M; Imagawa K; Hosoda Y; Kinoshita S; Koizumi N
PLoS One; 2013; 8(7):e69009. PubMed ID: 23894393
[TBL] [Abstract][Full Text] [Related]
13. Human mesenchymal stem cells-conditioned medium improves diabetic wound healing mainly through modulating fibroblast behaviors.
Saheli M; Bayat M; Ganji R; Hendudari F; Kheirjou R; Pakzad M; Najar B; Piryaei A
Arch Dermatol Res; 2020 Jul; 312(5):325-336. PubMed ID: 31786709
[TBL] [Abstract][Full Text] [Related]
14. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
[TBL] [Abstract][Full Text] [Related]
16. Substance P improves MSC-mediated RPE regeneration by modulating PDGF-BB.
Jung J; Jeong J; Hong HS
Biochem Biophys Res Commun; 2019 Aug; 515(4):524-530. PubMed ID: 31176487
[TBL] [Abstract][Full Text] [Related]
17. Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction.
Squecco R; Tani A; Chellini F; Garella R; Idrizaj E; Rosa I; Zecchi-Orlandini S; Manetti M; Sassoli C
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807453
[TBL] [Abstract][Full Text] [Related]
18. Sustainable Production and Activity Determination of Serum-Free Conditioned Medium from Menstrual Blood-Derived Endometrial Stem Cells.
Shang L; Zhang R; Yan J; Lu Y; Zhang S; Sun Y; Cheng H; Liu Y; Lin J
Appl Biochem Biotechnol; 2023 Feb; 195(2):1109-1121. PubMed ID: 36327033
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke.
Asgari Taei A; Dargahi L; Khodabakhsh P; Kadivar M; Farahmandfar M
CNS Neurosci Ther; 2022 Sep; 28(9):1425-1438. PubMed ID: 35715988
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional cell culture (3DCC) improves secretion of signaling molecules of mesenchymal stem cells (MSCs).
Al-Shaibani MBH
Biotechnol Lett; 2022 Jan; 44(1):143-155. PubMed ID: 35000031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
